Village Farms demonstrates a solid core business model anchored in integrated cultivation of cannabis and fresh produce, with defensible market positions in Canada and growing international presence. The company’s strategic pivot toward profitable product lines and international markets addresses m…
Village Farms International (VFF) Q4 2024: Canadian Cannabis Inventory Write-Down Clouds Profitable Growth Momentum
Village Farms reported strong organic growth in Canadian cannabis and fresh produce, but a $10.5 million non-cash inventory impairment on non-flower cannabis products weighed on adjusted EBITDA. The company is prioritizing profitable sales growth and international expansion, including a major capacity increase in the Netherlands, while optimizing Canadian operations for efficiency and margin improvement in 2025.
Summary
- Strategic Refocus on Profitability: Village Farms is shifting away from low-margin Canadian cannabis products to prioritize profitable growth and international markets.
- Operational Efficiency Initiatives: Optimization efforts in Canadian cannabis subsidiaries and fresh produce yield improvements underpin margin expansion.
- Global Expansion Acceleration: Significant investments in international medicinal cannabis exports and Dutch recreational market capacity signal growth beyond Canada.
Business Overview
Village Farms International operates primarily in three segments: Canadian cannabis, U.S. cannabis, and fresh produce. The company generates revenue through cultivation and sale of cannabis products, including dried flower, pre-rolls, and vapes, as well as fresh produce grown in greenhouses. Canadian cannabis represents a major portion of sales, supplemented by growing international medicinal cannabis exports and a developing recreational cannabis business in the Netherlands. The fresh produce segment contributes significantly through greenhouse-grown vegetables sold in the U.S. market.
Performance Analysis
Village Farms posted consolidated Q4 revenues of $82.6 million, an 11% increase year-over-year, driven by 10% growth in Canadian cannabis net sales and a 17% increase in fresh produce sales. Despite this top-line strength, the quarter’s adjusted EBITDA was a negative $3.5 million, heavily impacted by a $10.5 million non-cash inventory write-down related to non-flower cannabis products, primarily vapes, that failed to meet the company’s quality standards. Excluding this impairment, adjusted EBITDA would have been a positive $7 million, marking the best quarterly profitability in four years.
The impairment reflects a strategic decision to prioritize brand integrity and long-term profitability over short-term sales of lower-quality third-party manufactured products. Retail branded sales remained flat, while non-branded and international medicinal sales grew by 20% and 127% respectively in Canadian dollars. International medicinal exports, particularly to Germany, Australia, and the UK, are a high-margin growth driver, with the company expecting to triple these sales in 2025.
- Margin Pressure from Inventory Write-Down: Canadian cannabis gross margin fell to 2% due to the impairment but would have been 33% excluding it, aligning with the company’s 30-40% target range.
- Fresh Produce Turnaround: Fresh produce adjusted EBITDA improved to $4.1 million from a loss last year, supported by operational efficiencies and a $3.5 million vendor settlement related to past crop losses.
- U.S. Cannabis Stabilization: The U.S. segment returned to positive adjusted EBITDA of $0.3 million with a 70% gross margin despite regulatory headwinds.
Cash flow from operations was positive for the third consecutive quarter, totaling $10.3 million for the full year, supported by strong operational discipline and excise tax payments timing. The balance sheet remains healthy with $24.6 million in cash and manageable net debt of $15.9 million. The company is actively refinancing debt to better align with its evolving business focus.
Executive Commentary
"Excluding the inventory impairment, it was one of our best quarters for both Canadian cannabis and our entire business on a consolidated basis in several years, as we generated positive adjusted EBITDA in each of our Canadian cannabis and U.S. cannabis and fresh produce businesses."
Michael DiGiglio, Chief Executive Officer
"We made the business decision to write these things down to net realizable value and or destroy some of it rather than continuing to put more cost into it just to move it out the door for cash flow purposes. Very strong cash flow. Obviously, our cash flow was significantly higher than EBITDA."
Steve Graffini, Chief Financial Officer
Strategic Positioning
1. Prioritizing Profitable Growth in Canadian Cannabis
Village Farms is consciously exiting lower-tier, low-margin cannabis products, particularly in the vape and manufactured segments purchased from third parties. This strategy aligns with maintaining brand quality and focusing resources on higher-margin offerings such as dried flower and proprietary vape products like the recently launched Super Toast. The company remains a top-three Canadian cannabis producer with leading market shares in dried flower and pre-roll categories, but is shifting emphasis toward profitability over volume growth.
2. Accelerating International Medicinal Cannabis Expansion
International medicinal exports grew 113% in Q4, driven by demand in Germany, Australia, and the UK. With the addition of New Zealand as a fifth market, Village Farms aims to triple international medicinal cannabis sales in 2025. This segment offers higher margins and avoids Canadian excise taxes, making it a strategic growth lever. The company is cultivating a robust pipeline of new markets and customers to support this expansion.
3. Scaling Recreational Cannabis in the Netherlands
Leli Holland, Village Farms’ Dutch subsidiary, completed its first harvest and began sales to coffee shops in early 2025. The company is breaking ground on a Phase II indoor cultivation facility in Groningen, expected to quintuple annual production capacity by Q4 2025. The Dutch market offers favorable pricing and regulatory conditions compared to Canada, positioning Village Farms for a significant foothold in European recreational cannabis.
4. Enhancing Operational Efficiency and Integration
Village Farms is optimizing Canadian cannabis operations by improving resource allocation between its Pure Sunfarms and Rose subsidiaries to reduce costs and boost productivity. In fresh produce, the company is leveraging artificial intelligence and automation to increase yields and lower labor costs, contributing to margin expansion. These initiatives are expected to improve profitability and operational resilience.
5. Managing Regulatory and Tariff Risks
The company is preparing for potential U.S. tariffs on imports by shifting supply to its Texas greenhouse operations and passing through tariff costs where necessary. Additionally, it continues to navigate complex regulatory environments in the U.S. cannabis market, including pending rescheduling of marijuana and licensing approvals, while maintaining compliance and cost discipline.
Key Considerations
Village Farms’ Q4 results reflect a deliberate pivot toward quality and profitability over volume, particularly in Canadian cannabis. The inventory impairment, while a short-term earnings headwind, underscores management’s commitment to brand integrity and long-term value creation. The international and Dutch recreational markets represent significant growth opportunities that could diversify revenue streams beyond the mature and competitive Canadian market.
- Inventory Quality Focus: Write-down of third-party vape inventory signals stricter quality controls and a shift to in-house manufacturing.
- International Growth Trajectory: Tripling of medicinal exports in 2025 underpins a strategic priority for higher-margin markets.
- Dutch Expansion Scale: Phase II facility will dramatically increase production capacity, leveraging favorable local market dynamics.
- Operational Synergies: Integration and efficiency improvements in Canadian cannabis and fresh produce aim to sustain margin recovery.
- Capital Structure Optimization: Debt refinancing and new financing arrangements in progress to support growth initiatives.
Risks
Village Farms faces risks from regulatory uncertainties in the U.S. cannabis market, including delayed licensing and policy changes. The timing and impact of potential U.S. tariffs on produce imports could pressure margins despite mitigation efforts. The competitive Canadian cannabis market remains challenging, with ongoing pricing pressures and excise taxes that weigh on profitability. Execution risks related to scaling international operations and the Dutch facility also warrant investor attention.
Forward Outlook
For Q1 2025, management expects continued momentum in Canadian cannabis with operational efficiencies coming online and strong international sales growth. The company anticipates completing the optimization of Canadian cannabis subsidiaries by the end of Q1, which should enhance profitability. For the full year 2025, Village Farms aims to triple international medicinal cannabis exports and commission the Phase II Dutch facility by Q4, significantly increasing recreational cannabis production capacity. Management highlighted ongoing efforts to bring extraction and vape manufacturing in-house to capitalize on profitable market share opportunities.
Takeaways
Village Farms is navigating a complex cannabis and produce market environment by prioritizing profitability and quality over volume, evidenced by the $10.5 million inventory impairment decision. The company’s strong market positions in Canadian cannabis, combined with aggressive international expansion and operational improvements, position it for sustainable growth. Investors should monitor execution of international scaling, Dutch facility ramp-up, and regulatory developments that will shape the company’s trajectory beyond 2025.
- Profitability Over Volume: The strategic write-down and product portfolio pruning reinforce a disciplined approach to margin enhancement in Canadian cannabis.
- International and Dutch Growth: Expanding medicinal exports and Dutch recreational production offer diversified revenue streams with higher margin profiles.
- Operational and Financial Discipline: Efficiency initiatives and refinancing efforts support improved cash flow and balance sheet flexibility amid growth investments.
Conclusion
Village Farms’ Q4 2024 results demonstrate a pivotal moment in its evolution, balancing strong organic growth with strategic portfolio realignment. Despite the earnings impact of inventory impairment, the company’s focus on profitable growth, international expansion, and operational efficiency sets a foundation for a transformational 2025 and beyond.
Industry Read-Through
Village Farms’ experience highlights a broader cannabis industry trend of shifting away from low-margin commoditized products toward premium, quality-driven offerings supported by in-house manufacturing. The rapid growth in international medicinal cannabis exports underscores emerging global demand and regulatory openings that other operators should watch closely. Additionally, the Dutch recreational market expansion offers a model for regulated cannabis markets with favorable pricing and integration potential. Produce tariffs and supply chain adjustments in North America may also pressure industry peers to optimize sourcing and cost structures.